Capital Expenditures for Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's current capital expenditures (TTM) is $14.26M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$14.26M
YoY change
+55.1%
5Y CAGR
+40.4%
Peak year (2025)
$15.99M
Cumulative capital expenditures
$59.97M
CapEx history chart for Revolution Medicines (RVMD) from 2017 to 2025
CapEx history table for Revolution Medicines (RVMD) from 2017 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $15.99M | +55.1% | +$5.68M | ||
| 2024 | $10.31M | +33.4% | +$2.58M | ||
| 2023 | $7.73M | -28.5% | -$3.09M | ||
| 2022 | $10.82M | +65.7% | +$4.29M | ||
| 2021 | $6.53M | +122.6% | +$3.60M | ||
| 2020 | $2.93M | +13.3% | +$344,000 | ||
| 2019 | $2.59M | +72.7% | +$1.09M | ||
| 2018 | $1.50M | -4.8% | -$76,000 | ||
| 2017 | $1.57M | — | — |
CapEx values are taken from Revolution Medicines's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Revolution Medicines (RVMD) capital expenditures is $15.99M – surged 55.1% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Revolution Medicines capital expenditures compounded at +40.4% per year, sustaining 2 straight years of year-over-year growth.
Across the available history, capital expenditures reached its high of $15.99M in 2025 and its low of $1.50M in 2018.
Within Healthcare, Revolution Medicines (RVMD) ranks 9th among 8 peers we track. The peer median for capital expenditures is $3.87B.
Revolution Medicines Capital Expenditures by Year
Revolution Medicines Capital Expenditures 2025: $15.99M
Revolution Medicines capital expenditures in 2025 was $15.99M, surged 55.1% from 2024. This figure represents the highest annual value in the available history.
Revolution Medicines Capital Expenditures 2024: $10.31M
Revolution Medicines capital expenditures in 2024 was $10.31M, surged 33.4% from 2023.
Revolution Medicines Capital Expenditures 2023: $7.73M
Revolution Medicines capital expenditures in 2023 was $7.73M, declined 28.5% below 2022.
Revolution Medicines Capital Expenditures 2022: $10.82M
Revolution Medicines capital expenditures in 2022 was $10.82M, surged 65.7% from 2021.
Revolution Medicines Capital Expenditures 2021: $6.53M
Revolution Medicines capital expenditures in 2021 was $6.53M.
See more financial history for Revolution Medicines (RVMD).
Sector peers — CapEx
Companies in the same sector as Revolution Medicines, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk (NVO) | $90.11B | Healthcare |
| Eli Lilly (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group (UNH) | $3.62B | Healthcare |
| AstraZeneca (AZN) | $2.81B | Healthcare |
| Amgen (AMGN) | $1.86B | Healthcare |
| AbbVie (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Revolution Medicines's capital expenditures?
Latest reported capital expenditures for Revolution Medicines (RVMD) is $14.26M (period ending March 31, 2026).
How has Revolution Medicines capital expenditures changed year-over-year?
Revolution Medicines (RVMD) capital expenditures changed +55.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Revolution Medicines capital expenditures?
Revolution Medicines (RVMD) capital expenditures compound annual growth rate is +40.4% over the most recent 5 years available.
When did Revolution Medicines capital expenditures hit its highest annual value?
Revolution Medicines capital expenditures reached its highest annual value of $15.99M in 2025.
What was Revolution Medicines capital expenditures in 2024?
Revolution Medicines (RVMD) capital expenditures in 2024 was $10.31M.
What was Revolution Medicines capital expenditures in 2025?
Revolution Medicines (RVMD) capital expenditures in 2025 was $15.99M.
RVMD Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
RVMD Overview
Company profile, financial tools, and key metrics
RVMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RVMD How It Makes Money
Discover visual breakdown — where revenue comes from and where it goes.
RVMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RVMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RVMD Daily Price Character
Explosive · 50.7% historical win rate (green days). Streaks & record days.
RVMD Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.